RISK score for developing ventilator-associated pneumonia in children: The RISVAP study
- PMID: 35434973
- DOI: 10.1002/ppul.25929
RISK score for developing ventilator-associated pneumonia in children: The RISVAP study
Abstract
Objectives: Ventilator-associated pneumonia (VAP) is the second most common healthcare-associated infection in children. The aim of this study was to determine the risk factors for VAP in children and to create a risk score for developing VAP (RISVAP score).
Study design: It was a prospective observational study, including children who required mechanical ventilation (MV), registered in the multicentre ENVIN-HELICS database from 2014 to 2019. The regression coefficients of each independent risk factor for VAP were used to create the RISVAP score. Each factor scored 0 if it was absent, or, if it was present, an assigned value from 1 to 7, according to the regression coefficient.
Results: A total of 3798 patients were included, 97(2.5%) developing VAP. The independent risk factors for VAP were: female (odds ratio [OR]: 1.642, p = 0.024), MV > 4 days (OR: 26.79, p < 0.001), length in pediatric intensive care unit > 7 days (OR: 11.74, p < 0.001), and previous colonisation (OR: 4.18, p < 0.001). The RISVAP was calculated for each patient as the sum of all the independent risk factors. Three risk groups were obtained: low (0-5 points), intermediate (6-12 points), and high risk for VAP (13-16 points). The area under the curve for the final score was 0.905 (95%confidence interval: 0.888-0.923, p < 0.001).
Conclusions: The RISVAP is the first risk score for VAP in pediatric populations. Using this predictive score, might be helpful to detect vulnerable patients and therefore implement preventative strategies.
Keywords: healthcare-associated infection; intensive care; pediatrics; ventilator-associated pneumonia.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Chomton M, Brossier D, Sauthier M, et al. Ventilator-associated pneumonia and events in pediatric intensive care: a single center study. Pediatr Crit Care Med. 2018;19(12):1106-1113.
-
- Salmanov A, Litus V, Vdovychenko S, et al. Healthcare-associated infections in intensive care units. Wiad Lek. 2019;72:963-969.
-
- Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111.
-
- Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13(8):665-671.
-
- Wu D, Wu C, Zhang S, Zhong Y. Risk factors of ventilator-associated pneumonia in critically iii patients. Front Pharmacol. 2019;10:482.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
